ARTEMISMED2024-04-012024-06-30 ARTEMISMED2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member ARTEMISMED2024-06-30 ARTEMISMED2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ARTEMISMED2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 542919 ARTEMISMED NOTLISTED Artemis Medicare Services Limited Equity 2024-04-01 2025-03-31 2024-08-08 2024-08-01 INR Lakhs First quarter 14:45:00 15:35:00 2024-08-08 2024-08-08 Not applicable Single segment Healthcare Services 2024-04-01 2024-06-30 Unaudited Consolidated 2232038000.00 44038000.00 2276076000.00 793748000.00 0.00 54000.00 358851000.00 81339000.00 107993000.00 717700000.00 2059685000.00 216391000.00 0.00 216391000.00 46397000.00 4751000.00 51148000.00 0.00 165243000.00 0.00 0.00 0.00 0.00 165243000.00 -599000.00 164644000.00 166668000.00 -1425000.00 166071000.00 -1427000.00 136916000.00 1 1.14 1.12 0.00 0.00 1.14 1.12 The value of Earning per share for the quarter is not annualised. Notes: 1. The above consolidated unaudited financial results for the quarter ended June 30, 2024 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on August 08, 2024. The statutory auditors have expressed unmodified conclusion on the aforesaid results. 2. The consolidated Unaudited financial results includes the results of the Company and one subsidiary. The Company together with its subsidiary is herein referred to as the Group. 3. The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended (Ind AS), as prescribed under Section 133 of the Companies Act 2013 (the 'Act') read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended) and the other recognised accounting practices and policies to the extent applicable and is in compliance with presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (as amended). Please Refer remaining notes from Un-audited financial results filed in PDF format. Other Expenses 717700000.00 Remeasurement of defined employee benefit plans -2499000.00 Deferred Tax adjustment on revaluation that will not be reclassified to profit or loss 1271000.00 -1228000.00 -629000.00 0.00